SecBot SecBot
PRESS-RELEASE ·Filed Nov 6, 2026

CHE

Chemed Corp.
NEUTRAL
Impact 2/10
Horizonimmediate Processed10d 13h ago WireGlobeNewswire
Press release · Dividend
Actionable Insight • Neutral

Dividend unchanged, no signal of change in capital allocation policy. Monitor next quarterly earnings for any update on payout ratio or buyback activity.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$528.05
T+0 close · Nov 6, 2026 · via day close
Latest settled
+3.82%
T+5 · $548.20
Vs SPY
+1.22%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $528.05entry
  2. T+1 · 8d ago +1.90%α −0.47% · $538.06
  3. T+5 · 4d ago +3.82%α +1.22% · $548.20
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Chemed Corp. declared a quarterly cash dividend of $0.70 per share, unchanged from the prior quarter, marking the 222nd consecutive quarterly dividend. The dividend is payable December 4, 2026 to holders of record November 16, 2026. This is a routine capital return announcement with no change in dividend policy.

Key Facts

  • Quarterly dividend of $0.70 per share declared
  • Dividend unchanged from September 2026 payment
  • 222nd consecutive quarterly dividend in 55 years as a public company
  • Payable December 4, 2026 to shareholders of record November 16, 2026

Financial Impact

Quarterly dividend of $0.70 per share, unchanged; annualized $2.80 per share represents approximately 0.4% of market cap based on current market cap of $7.1B

dividend yield

Risk Factors

  • No change in dividend suggests stable but not increasing capital return
  • Forward-looking statements subject to inherent risks

Market Snapshot

Exchange
NYSE
Sector
Services-Home Health Care Services
Analyst Consensus
67% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3397756

Track record

19 reports on CHE

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +2.86% at T+5 after the Oct 27, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 6, 202610d ago Press Release Neutral 2/10 Viewing Entry $528.05 to $548.20 Now $549.45 +4.05% ▲ +3.82% +1.22% vs SPY
  2. Nov 5, 202611d ago Insider Cluster Bearish 4/10 Entry $533.77 to $550.20 Now $549.45 −2.94% ▼ −3.08% +0.21% vs SPY
  3. Nov 3, 202613d ago 144 Neutral 2/10 Entry $533.65 to $544.49 Now $549.45 +2.96% ▲ +2.03% +2.62% vs SPY
  4. Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
  5. Oct 27, 202620d ago 8-K Bullish 6/10 No price data
  6. Oct 27, 202620d ago Press Release Bullish 6/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
  7. Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $512.98 to $534.72 Now $549.45 +7.11% ▲ +4.24% +4.80% vs SPY
  8. Oct 1, 20266w ago Press Release Neutral 1/10 Entry $502.90 to $498.25 Now $549.45 +9.26% ▼ −0.92% −2.23% vs SPY
  9. Sep 16, 20268w ago Press Release Neutral 4/10 Entry $505.97 to $495.65 Now $549.45 +8.59% ▼ −2.04% −2.64% vs SPY
  10. Aug 24, 202612w ago Insider Cluster Neutral 3/10 Entry $541.34 to $518.71 Now $549.45 +1.50% ▼ −4.18% −4.65% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 8h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026